These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15613424)

  • 1. Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic Acid microarrays identifies several candidate genes as markers of malignancy.
    de Fraipont F; El Atifi M; Cherradi N; Le Moigne G; Defaye G; Houlgatte R; Bertherat J; Bertagna X; Plouin PF; Baudin E; Berger F; Gicquel C; Chabre O; Feige JJ
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1819-29. PubMed ID: 15613424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival.
    de Reyniès A; Assié G; Rickman DS; Tissier F; Groussin L; René-Corail F; Dousset B; Bertagna X; Clauser E; Bertherat J
    J Clin Oncol; 2009 Mar; 27(7):1108-15. PubMed ID: 19139432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Gaston V; Coste J; Louvel A; Baudin E; Bertherat J; Chapuis Y; Duclos JM; Schlumberger M; Plouin PF; Luton JP; Le Bouc Y
    Cancer Res; 2001 Sep; 61(18):6762-7. PubMed ID: 11559548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis by cDNA microarrays of gene expression patterns of human adrenocortical tumors.
    Slater EP; Diehl SM; Langer P; Samans B; Ramaswamy A; Zielke A; Bartsch DK
    Eur J Endocrinol; 2006 Apr; 154(4):587-98. PubMed ID: 16556722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
    Faria AM; Almeida MQ
    Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy.
    Velázquez-Fernández D; Laurell C; Geli J; Höög A; Odeberg J; Kjellman M; Lundeberg J; Hamberger B; Nilsson P; Bäckdahl M
    Surgery; 2005 Dec; 138(6):1087-94. PubMed ID: 16360395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.
    Gicquel C; Bertagna X; Schneid H; Francillard-Leblond M; Luton JP; Girard F; Le Bouc Y
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1444-53. PubMed ID: 7911125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.
    Gicquel C; Raffin-Sanson ML; Gaston V; Bertagna X; Plouin PF; Schlumberger M; Louvel A; Luton JP; Le Bouc Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2559-65. PubMed ID: 9253334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors.
    Almeida MQ; Fragoso MC; Lotfi CF; Santos MG; Nishi MY; Costa MH; Lerario AM; Maciel CC; Mattos GE; Jorge AA; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3524-31. PubMed ID: 18611974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling enables molecular classification of adrenocortical tumours.
    Laurell C; Velázquez-Fernández D; Lindsten K; Juhlin C; Enberg U; Geli J; Höög A; Kjellman M; Lundeberg J; Hamberger B; Larsson C; Nilsson P; Bäckdahl M
    Eur J Endocrinol; 2009 Jul; 161(1):141-52. PubMed ID: 19411298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.
    de Fraipont F; El Atifi M; Gicquel C; Bertagna X; Chambaz EM; Feige JJ
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4734-41. PubMed ID: 11134136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis.
    André F; Michiels S; Dessen P; Scott V; Suciu V; Uzan C; Lazar V; Lacroix L; Vassal G; Spielmann M; Vielh P; Delaloge S
    Lancet Oncol; 2009 Apr; 10(4):381-90. PubMed ID: 19249242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors.
    Lefrançois-Martinez AM; Bertherat J; Val P; Tournaire C; Gallo-Payet N; Hyndman D; Veyssière G; Bertagna X; Jean C; Martinez A
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3010-9. PubMed ID: 15181092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors.
    Fonseca AL; Kugelberg J; Starker LF; Scholl U; Choi M; Hellman P; Åkerström G; Westin G; Lifton RP; Björklund P; Carling T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):949-60. PubMed ID: 22733721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.